Applied Genetic Technologies reported $500K in Sales Revenues for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Alimera Sciences ALIM:US $ 21.7M 10.49M
Applied Genetic Technologies AGTC:US $ 0.5M 0.5M
Biogen BIIB:US $ 2778.9M 3.9M
Bluebird Bio BLUE:US $ 7.47M 5.32M
Celldex Therapeutics CLDX:US $ 3.48M 2.8M
Gilead Sciences GILD:US $ 6217M 206M
Insmed INSM:US $ 45.37M 5.15M
Intercept Pharmaceuticals ICPT:US $ 96.58M 14.92M
Life Technologies LIFE:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 5138.5M 2609.8M
Rigel Pharmaceuticals RIGL:US $ 26.27M 54.75M
Ultragenyx Pharmaceutical RARE:US $ 86.98M 12.42M